Highest-materiality recent filing
Aveanna completes $175.5M acquisition of Family First Homecare; raises FY2026 guidance
Completed acquisition of Family First Homecare for $175.5M cash, funded from cash on hand.
Aveanna reprices $1.32B first lien debt, margin cut 50 bps; potential 25 bps more
Entered 13th amendment to first lien credit agreement; $1.318B term loans and $250M revolver repriced.
Aveanna Q1 revenue up 15.9% to $647.9M; net income $41.7M vs $5.2M; raises FY guidance
Q1 revenue $647.9M (+15.9% YoY); net income $41.7M vs $5.2M in prior-year period.
Aveanna Q4 revenue $662.5M (+27.4% YoY); net income $178.8M; acquires Family First Homecare
Q4 revenue $662.5M (+27.4% YoY); net income $178.8M vs $29.2M prior year.
Aveanna to acquire Family First Homecare for $175.5M in cash, expands pediatric home care footprint
Purchase price of $175.5 million in cash, subject to working capital and other adjustments.
Aveanna raises FY2025 revenue and EBITDA guidance; issues FY2026 outlook
FY2025 revenue guidance raised to ~$2.425-2.445B from >$2.375B.
Aveanna Q3 revenue up 22.2% to $621.9M; net income of $14.1M vs loss; raises FY guidance
Q3 revenue $621.9M (+22.2% YoY); net income $14.1M vs loss of $42.8M in prior year.
Aveanna Healthcare prelim Q3 revenue $616-624M, net income up ~130%
Revenue expected $616M-$624M, up ~21.0%-22.6% YoY.
Aveanna completes $1.325B refinancing; extends maturities, repays $415M second lien debt
New $1.325B first lien term loans refinance $886M existing loans and add $439M incremental; maturity 2032 at SOFR+3.75%.
Aveanna Q2 revenue $589.6M (+16.8% YoY); net income $27.0M; raises FY guidance
Q2 revenue $589.6M, up 16.8% YoY; net income $27.0M vs $13.9M.
Aveanna increases receivables financing facility to $275M and extends maturity by three years
Seventh Amendment to Receivables Financing Agreement raises maximum availability to $275.0 million.
Aveanna completes acquisition of Thrive Skilled Pediatric Care, issues 11.18M shares
Closed acquisition of Thrive SPC on June 2, 2025; issued 11,184,588 shares of common stock as merger consideration.
Aveanna Q1: net income $5.2M vs loss; revenue +14% to $559.2M; raises FY25 guidance
Revenue $559.2M (+14.0% YoY); gross margin 32.8% vs 29.7%.
Aveanna to acquire Thrive Skilled Pediatric Care for ~$75M in stock and cash
Aveanna (AVAH) to acquire Thrive SPC for ~$75M, primarily in common stock, plus cash.
Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.
Aveanna Q3 revenue $509M (+6.5% YoY); Adj EBITDA $47.8M (+32.2%); raises FY24 guidance
Q3 revenue $509.0M, up 6.5% YoY; gross margin improved to 31.4% from 30.8%.
Aveanna Q2 revenue $505M (+7% YoY); Adj. EBITDA up 27.3%; raises FY guidance
Revenue $505M, up 7% YoY; gross margin $158.3M (+1.9%).
Aveanna Q1 revenue $490.7M (+5.2%), net loss narrows to $11.2M; raises FY2024 guidance
Q1 revenue $490.7M (+5.2% YoY); gross margin $145.9M (29.7% of revenue).
Aveanna Q4 revenue up 6.1% to $478.8M; adjusted EBITDA +30.4%; FY2024 guidance issued
Q4 revenue $478.8M (+6.1% YoY), driven by Private Duty Services and Medical Solutions growth; Home Health & Hospice down slightly.
On March 27, 2025, and with immediate effect, Dr. Sheldon Retchin, a Class III Director of Aveanna Healthcare Holdings Inc., a Delaware corporation (the "Company"), notified the Company of his resignation from the Company's Board of Directors for personal health reasons.
On November 1, 2024, the Board of Directors (the “Board”) of Aveanna Healthcare Holdings Inc. (the “Company”) appointed Brent Layton to serve as a Class III director and as a member of the Audit Committee of the Board (the “Audit Committee”), to fill a vacancy.
Max materiality 0.85 · Median 0.50 · Most common event earnings